Nanomik Biotechnology has successfully completed its pre-Series A bridge round, securing €1.08M investment led by Arya VC with participation from T3 GSYF managed by APY Ventures, Technology and Innovation Fund, Derin Technology GSYF, and strategic partner ITU ARI Teknokent. This funding will enable the company to expand its patented microencapsulation technology offering biological alternatives to chemicals across agriculture, food, and construction sectors in the US, Turkey, and EMEA markets, while enhancing R&D capabilities and establishing global sales channels.
Igniters Tech Law is proud to have advised and represented Nanomik Biotechnology throughout this process.